Rethinking Cancer Through AI and Precision Medicine with Dr. Pedram Razavi, Memorial Sloan Kettering Cancer Center

Listen to this episode from Decoded on Spotify. Cancer has been described for a long time, yet only now are we beginning to truly decode it.In this episode of Decoded, Dr. Jurgi Camblong, Founder of SOPHiA GENETICS, speaks with Dr. Pedram Razavi, Director of Liquid Biopsy and Cancer Genomics at Memorial Sloan Kettering Cancer Center. From the first historical mentions of tumors to today’s breakthroughs in precision oncology, Dr. Razavi shares how genomics, liquid biopsy, and AI are reshaping the way we detect, treat, and even think about cancer. Along the way, Dr. Razavi shares personal stories - the human moments that drive discovery.In this exciting episode of Decoded, you'll hear:• The evolving definition of cancer - what makes cancer “selfish,” and why some tumors adapt• How breast oncology helped pioneer precision medicine• Why liquid biopsy may let us anticipate resistance before it appears• The art of oncology: data, science, and the patient in front of youThis conversation bridges history, science, and the future - for clinicians and researchers, patients and families, and anyone who wants to understand how cancer care is changing.